Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
br Conclusions br Conflict of
2020-08-05

Conclusions Conflict of interest Acknowledgements The authors are supported by National Institutes of Health grants (CA162804, CA92584, and CA13499 to DJC and CA166677 to BPPC) and Cancer Prevention and Research Institute of Texas (RP110465 to DJC). The cellular response to DNA double-st
-
Besides chemopreventive effects against oxidative
2020-08-05

Besides chemopreventive effects against oxidative DNA damage we evaluated the protective effects of the three Hypericum sp. and isolated compounds against alkylating DNA damage induced by MMS in HT29 cells. Human exposure to alkylating agents, from different sources, occurs in a continuous way and i
-
br CXCR In mammals CXCR is
2020-08-05

CXCR3 In mammals CXCR3 is the sole receptor shared by three closely related ELR- chemokines CXCL9–11 and also interacts with CXCL4 and CCL21 (Lacotte et al., 2009, Soto et al., 1998). CXCL9–11 can be induced by the Th1 signature cytokine IFN-γ and hence are referred to as IFN-γ inducible proteins
-
Toxicological and safety studies performed to complete the p
2020-08-05

Toxicological and safety studies performed to complete the profile of LAS191589 showed that so far, it is a safe compound. No issues have been detected in any of the studies performed in terms of cytotoxicity, cardiovascular safety, central nervous system safety and genotoxicity. No relevant adverse
-
br Conclusion To our knowledge this study
2020-08-05

Conclusion To our knowledge, this study is the first to give evidence that the ETA selective antagonist BQ-123 reverses the cisplatin-induced ARF mainly via restoring SOD activity, in addition to other antioxidant parameters, NO, TNF-α and caspase-3 levels. And that this protective effect require
-
Steroid sexual hormones enter the
2020-08-05

Steroid sexual hormones enter the aquatic environment mainly via effluents from waste water treatment plants (WWTPs) (after incomplete removal in the plant) [10], [11]. Once in waterways, they may sorb to solid particles (bed sediments, soils) where estrogens and progestogens may persist for long pe
-
Acknowledgements We thank the University of Hull for funding
2020-08-04

Acknowledgements We thank the University of Hull for funding, BBSRC for support (GM), and the EPSRC National Mass Spectrometry Service (Swansea) for accurate mass determination of 2e and 3e. Introduction Mitochondria are vital organelles for most eukaryotic cells (Karnkowska et al., 2016). They
-
glutamate receptor Much less is known about
2020-08-04

Much less is known about the mechanism of DDR clustering and its role in the receptor function. It is understood that DDR1 exists as an inactive dimer on the cell surface and undergoes further oligomerization upon ligand binding (Abdulhussein et al., 2008, Noordeen et al., 2006, Mihai et al., 2009).
-
Urocortin is a selective CRF
2020-08-04

Urocortin 2 is a selective CRF2 Andarine peptide agonist with a Ki value of 0.66 nM for inhibition of radiolabeled sauvagine binding to recombinant mouse CRF2(b) receptors and >100 nM for the recombinant human CRF1 receptor (Reyes et al., 2001). Antisauvagine-30 is a selective CRF2 receptor peptide
-
Urocortin is a selective CRF
2020-08-04

Urocortin 2 is a selective CRF2 ML-265 receptor peptide agonist with a Ki value of 0.66 nM for inhibition of radiolabeled sauvagine binding to recombinant mouse CRF2(b) receptors and >100 nM for the recombinant human CRF1 receptor (Reyes et al., 2001). Antisauvagine-30 is a selective CRF2 receptor p
-
eletriptan sale br Discussion br Concluding remarks br Ackno
2020-08-04

Discussion Concluding remarks Acknowledgments The current study was supported by the Discovery grant from Natural Science and Technology Research Council of Canada (NSERC, RFN.356021) and by Louise and Alan Edwards Foundation Grant in Pain Research (RFN.68772) to Weiya Ma. This study has no
-
Studies into regulation of p via PTM processes that
2020-08-04

Studies into regulation of p53 via PTM processes that involve phosphorylation, acetylation, ubiquitination, SUMOylation, neddylation, and methylation are being increasingly reported [23], [24]. Phosphorylation and acetylation of p53 stimulate p53-associated transcription factors [25], [26], whereas
-
We found that the postnatal
2020-08-04

We found that the postnatal absence of norepinephrine yields differing effects depending on noradrenergic receptor type and β-Sitosterol region. The density of α1-AR, indicated by [3H]prazosin binding was similar between Dbh+/− and Dbh−/− mice except for a significant increase in hippocampus in Dbh
-
Although the pathophysiology of RLS is not fully
2020-08-04

Although the pathophysiology of RLS is not fully understood, evidence indicates that both iron deficiency and dopaminergic abnormalities are involved in its etiology. As iron is a major cofactor in dopaminergic neurotransmission, iron deficits may produce dopaminergic changes that exacerbate RLS sym
-
Taking a pragmatic approach with a view to complete the
2020-08-04

Taking a pragmatic approach with a view to complete the study and because chemotherapy regimens in NETs are not standardized, we do not impose a specific regimen in both arms. However, one regimen in each arm is recommended in order to reduce heterogeneity: the ALKY-based chemotherapy arm will recei
16061 records 794/1071 page Previous Next First page 上5页 791792793794795 下5页 Last page